z-logo
HomeZAIABlog
open-access-imgOpen Access
miR-21 protects against lipopolysaccharide-stimulated acute kidney injury and apoptosis by targeting CDK6
Author(s) -
Wei Wei,
Yuanyuan Yao,
Hongyuan Bi,
Zhe Zhai,
Yan Gao
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2020.03.01
Subject(s) - acute kidney injury , lipopolysaccharide , apoptosis , medicine , cancer research , cyclin dependent kinase 6 , pharmacology , immunology , biology , cell cycle , biochemistry , cyclin dependent kinase
Current evidences suggest that miR-21 has a potential application in treating septic AKI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.